Earnings results for Repare Therapeutics (NASDAQ:VERX)
Vertex, Inc. is expected* to report earnings on 09/09/2020 before market open. The report will be for the fiscal Quarter ending Jun 2020. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.08.
Analyst Opinion on Repare Therapeutics (NASDAQ:VERX)
9 Wall Street analysts have issued ratings and price targets for Repare Therapeutics in the last 12 months. Their average twelve-month price target is $30.00, predicting that the stock has a possible upside of 28.48%. The high price target for VERX is $34.00 and the low price target for VERX is $23.00. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of “Hold.”
Repare Therapeutics has received a consensus rating of Hold. The company’s average rating score is 2.44, and is based on 4 buy ratings, 5 hold ratings, and no sell ratings. According to analysts’ consensus price target of $30.00, Repare Therapeutics has a forecasted upside of 28.5% from its current price of $23.35. Repare Therapeutics has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Dividend Strength: Repare Therapeutics (NASDAQ:VERX)
Repare Therapeutics does not currently pay a dividend. Repare Therapeutics does not have a long track record of dividend growth.
Insiders buying/selling: Repare Therapeutics (NASDAQ:VERX)
In the past three months, Repare Therapeutics insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,856,623.00 in company stock.
Earnings and Valuation of Repare Therapeutics (NASDAQ:VERX
Earnings for Repare Therapeutics are expected to decrease by -36.00% in the coming year, from $0.25 to $0.16 per share.
More latest stories: here